454
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Advantages of Conducting Clinical Trials in Bulgaria (1995–2009)

Pages 2049-2053 | Published online: 15 Apr 2014

REFERENCES

  • Benisheva T, Clinical trials in the EU and in Bulgaria incl., Bulletin of BACR 1/2008, p 8–13;
  • Clinical Trials.gov is a registry of federally and privately supported clinical trials conducted in the United States and around the world.www.clinicaltrials.gov (access 24.of Oct 2010)
  • Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. OJ.2001;L-12:34–44
  • Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (Consolided version: 30/12/2008). http://www.efgcp.be/html.asp?what=efgcpreport.htm&L1=5&L2=1#report
  • ICREL European forum for good clinical practice.Project final report.
  • International Conference on Harmonisation of Technical requirements for the registration of Pharmaceuticals for Human use (ICH). ICH E 6, Good Clinical Practice, Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95). www.ich.org
  • Kalberg J. Pe, Industry clinical testing of new medicinal products requires 95 000 study sites and 1300000 annually.101–109 Clinical trial magnifier Vol.1/Issue 6, Jun 2008; www.ClinicalTrialMagnifier.com
  • Kalberg J. Pe, US FDA Site Inspection Findings, 1997–2008, Fail to justify Globalisation Concerns trial magnifier Vol. 1/Issue 2:4, Apr 2009; 194–212 www.ClinicalTrialMagnifier.com
  • Kalberg J. Pe, West to East Drift in European Sponsored Clinical Trials Clinical trial Magnifier Vol. 1/Issue 1, Jan 2008; 1–9. www.ClinicalTrialMagnifier.com
  • Kitov B., B. Borissov, T. Benisheva, Highlight recent changes to Bulgarian legislation. Reform of the Bulgarian Pharmaceutical Regulations. Reprinted from Regulatory Affairs Journal, 2000, Vol 1
  • Law on medicines and pharmacies in human medicine SG 36, 1995 repealed SG 31 from 13 April 2007.
  • Law on medicinal products in human medicine. SG. 31, 13of April 2007 Γ., last amend. SG22 from 12.Dec. 2009.
  • Platonov P. Clinical Trial in Russia and Eastern Europe: Recruitment and Qualit. Int. Clin. Pharmacol Ther 2003; 41;277–80.
  • Regulation & 14 of MoH SG 70 of 16 August 1996 (repealed SG 73 from 5 Sept.2000)
  • Regulation & 14 of MoH, SG73 from 31 July 2000 (repealed SG 67 from 17 of Aug. 2007)
  • Regulation & 31 OT 12.08.2007 (SG 67 from 17 of Aug. 2007)
  • The world fact book https://www.cia.gov/library/publications/the-world-factbook/index.html
  • Yearly report of Bulgarian Drug Agency (2002) www.bda.bg(access 24.of Oct 2010)
  • Yearly report of Bulgarian Drug Agency (2003) www.bda.bg (access 24.of Oct 2010)
  • Yearly report of Bulgarian Drug Agency (2004) www.bda.bg(access 24.of Oct 2010)
  • Yearly report of Bulgarian Drug Agency (2005) www.bda.bg(access 24.of Oct 2010)
  • Yearly report of Bulgarian Drug Agency (2006) www.bda.bg(access 24.of Oct 2010)
  • Yearly report of Bulgarian Drug Agency (2007) www.bda.bg(access 24.of Oct 2010)
  • Yearly report of Bulgarian Drug Agency (2008) www.bda.bg(access 24.of Oct 2010)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.